Despite the significant progress that has been achieved in the treatment of OCD, 20-30% of patients with OCD are still resistant to treatment. Also, whereas some patients respond very well, others exhibit only partial responses. The treatment of these patients usually requires higher doses and takes longer. In the treatment of resistant cases, it is important to maintain the patient's hope, along with a step-by-step logical approach such as that presented here. Further controlled trials in OCD will establish whether the drugs mentioned here will remain in the drug arsenal of OCD.
|Journal||International Journal of Psychiatry in Clinical Practice|
|Issue number||SUPPL. 1|
|State||Published - 1997|